SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001640455-21-000036
Filing Date
2021-02-12
Accepted
2021-02-12 08:08:02
Documents
2
Period of Report
2021-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_161313526933138.html 3  
1 FORM 3 wf-form3_161313526933138.xml 3 1727
2 EXHIBIT 24 - LIMITED POWER OF ATTORNEY powerofattorneyforsection1.htm EX-24 8306
  Complete submission text file 0001640455-21-000036.txt   11415
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GOSSAMER BIO, INC. 3013 SCIENCE PARK ROAD, SUITE 200 SAN DIEGO CA 92121
Business Address
Salter-Cid Luisa (Reporting) CIK: 0001766404 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37998 | Film No.: 21622912